Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pediatric Hematology and Oncology|January 1, 1989
Effects of 3-deazaadenosine, an inducer of HL-60 cell differentiation, on human blood cells in vitroS Prytz, T Loennechen, A Johansson, et al.Biochemical Pharmacology|October 9, 1991
Elevation of cyclic AMP levels in HL-60 cells accumulated in G1 or G2 by transmethylation inhibitorsP S Prytz, B E Bang, P C Endresen, et al.Journal of Neurology|March 4, 2022
Botulinum toxin treatment improves dysphagia in patients with oculopharyngeal muscular dystrophy and sporadic inclusion body myositisN Witting, D Daugaard, S Prytz, et al.Neuropsychobiology|January 1, 1979
The profile and severity of lithium-induced side effects in mentally healthy subjectsP Bech, J Thomsen, S Prytz, et al.European Journal of Neurology|December 3, 2003
Reduced jaw opening from paradoxical activity of mandibular elevator muscles treated with botulinum toxinM Bakke, L M Werdelin, T Dalager, et al.Acta Oto-Laryngologica|September 1, 1976
Lithium treatment of meniere's disease. Results of a double-blind cross-over trialJ Thomsen, P Bech, A Geisler, et al.Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1988
Catecholamine binding and concentrations in acute phase plasma after surgeryG Sager, T Trovik, L Slørdal, et al.Cancer Research|November 1, 1986
Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolaseJ Aarbakke, G A Miura, P S Prytz, et al.Journal of Clinical Pathology|October 21, 2000
Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern NorwayA Orbo, J P Baak, I Kleivan, et al.Pageof 3